A detailed history of Exane Derivatives transactions in Deckers Outdoor Corp stock. As of the latest transaction made, Exane Derivatives holds 2 shares of DECK stock, worth $342. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 380 99.47%
Holding current value
$342
Previous $104,000 100.0%
% of portfolio
0.0%
Previous 0.03%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$226.79 - $290.36 $85,726 - $109,756
-378 Reduced 99.47%
2 $0
Q1 2022

Apr 22, 2022

SELL
$234.8 - $367.94 $18,314 - $28,699
-78 Reduced 17.03%
380 $104,000
Q4 2021

Jan 28, 2022

SELL
$330.7 - $438.3 $46,959 - $62,238
-142 Reduced 23.67%
458 $167,000
Q3 2021

Oct 26, 2021

SELL
$360.2 - $439.94 $310,852 - $379,668
-863 Reduced 58.99%
600 $216,000
Q2 2021

Jul 28, 2021

BUY
$311.22 - $384.07 $170,548 - $210,470
548 Added 59.89%
1,463 $561,000
Q1 2021

Apr 30, 2021

SELL
$278.61 - $344.13 $109,215 - $134,898
-392 Reduced 29.99%
915 $302,000
Q4 2020

Jan 27, 2021

BUY
$234.97 - $304.27 $307,105 - $397,680
1,307 New
1,307 $374,000

Others Institutions Holding DECK

About DECKERS OUTDOOR CORP


  • Ticker DECK
  • Exchange NYSE
  • Sector Consumer Cyclical
  • Industry Footwear & Accessories
  • Shares Outstandng 26,531,000
  • Market Cap $4.55B
  • Description
  • Deckers Outdoor Corporation, together with its subsidiaries, designs, markets, and distributes footwear, apparel, and accessories for casual lifestyle use and high-performance activities. The company offers premium footwear, apparel, and accessories under the UGG brand name; sandals, shoes, and boots under the Teva brand name; and relaxed casual...
More about DECK
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.